Osteomyelitis: Farmakoterapi Infeksi Tulang

Download as pdf or txt
Download as pdf or txt
You are on page 1of 39

Osteomyelitis

Farmakoterapi
Infeksi Tulang

Wahyu Hendrarti
Osteomyelitis
 Infeksi yang terjadi pada tulang yang disebabkan oleh
Staphylococcus aureus dan beberapa patogen lainnya
yang dapat bersifat Akut dan Kronis.
 Tanda dan gejala osteomyelitis: Nyeri lokal dan
beberapa keadaan yg berefek pada tulang [inflamasi,
erythema, edema, dan keterbatasan dalam bergerak].
Pasien acute hematogenous osteomyelitis biasa juga
disertai demam, panas-dingin, dan malaise.
 The gold standard for diagnosis: bone biopsy dengan
mengisolasi microorganism(s) dari kultur dan melihat
keberadaan sel-sel inflamasi dan osteonecrosis pada uji
histologi.
Klasifikasi Osteomyelitis
 Osteomyelitis paling sering diklasifikasikan berdasarkan:
[1] Rute Infeksi [route of infection]
[2] Lama penyakit [duration of disease]

1
Menyebar a
dari aliran b
darah ke Menyebar
tulang dari
jaringan
terdekat

FIGURE 78–1. Classification by Route of Infection .


PATHOGENESIS
OF Osteomyelitis

1
Route of
Infection

Jaringan yang
nekrotik dan
terisolasi
Osteomyelitis is most often classified by

2
1
2
Duration of
Disease

2
Osteomyelitis
 The treatment goals for acute and
chronic osteomyelitis are to:
1) eradicate the infection and
2) prevent recurrence.
 Therefore, in chronic osteomyelitis, a
common treatment goal for many
patients is to prevent complications
such as amputation.
Osteomyelitis
 Treatment of osteomyelitis is dependent
on the extent of bone necrosis.
1. For acute osteomyelitis with
minimal bone destruction, an
extended course of antimicrobial
therapy should effectively treat the
infection;
2. however, in chronic osteomyelitis
surgical intervention is also typically
required.
Osteomyelitis
 Empiric antimicrobial therapy should target
likely causative pathogen(s) based on patient-
specific risk factors and route of infection.
 The total duration of antimicrobial therapy is
typically 4 to 6 weeks. Therapy is often
administered intravenously for 1 or 2 weeks and
then switched to the oral route.
 Patients should be monitored for clinical
response, development of adverse drug reactions,
and potential drug-drug interactions.
TABLE 78–1. Empiric
Antimicrobial Therapy for
Osteomyelitis

Ingat
Obatnya
!!!
TABLE 78–1. Empiric Antimicrobial Therapy for Osteomyelitis

Ingat
Obatnya
!!!
TABLE 78–1. Empiric Antimicrobial Therapy for Osteomyelitis

elderly
TABLE 78–1. Empiric Antimicrobial Therapy for
Osteomyelitis
Methicillin Sensitive
Staphylococcus aureus
Methicillin Resistant
Staphylococcus aureus
Belum pernah dilaporkan
interaksi obatnya
Belum pernah dilaporkan interaksi obatnya
Sumber
Terima
Kasih
Wahyu Hendrarti

You might also like